Skip to main content
Premium Trial:

Request an Annual Quote

Gerrit van den Dool, David Smoller, Shaf Yousaf, Richard Lerner

Sigma-Aldrich has promoted Gerrit van den Dool to the newly created position of vice president of sales and David Smoller to president of the company's research biotech business unit.
 
Van den Dool joined Sigma-Aldrich in 1999 as the head of European research sales. Prior to joining the firm, he worked in sales positions at Amersham-Pharmacia and Molecular Dynamics.
 
Smoller joined Sigma-Aldrich as vice president of research and development in 2004 after founding and selling two startups: Genome Systems and ProteoPlex.
 
Shaf Yousaf, the previous president of the research biotech business unit, has left the company, Sigma said.
 

 
Sequenom has elected Richard Lerner, president of the Scripps Research Institute, to its board of directors. Lerner is also the Lita Annenberg Hazen Professor of Immunochemistry, the Cecil H. and Ida M. Green Chair in Chemistry, and a member of the Skaggs Institute for Chemical Biology at Scripps and serves on the boards of Kraft Foods and Opko Health.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.